Although the precise mechanisms of cholinergic deficit in AD remain to be deeply elucidated, a growing body of evidence suggests that complex reciprocal interactions exist between central cholinergic changes and other pathophysiological features of AD, including abnormal Aβ protein, tau cascade and inflammation [7]. Here, MAPT is linked to Alzheimer disease.